Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
451
DELISTED
Walgreens Boots Alliance
WBA
| $57.8M | 0.03% |
1,364,009
+673,668
| +98% | +$28.6M |
|
|
SILK
452
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $57.7M | 0.03% |
1,377,428
-258,034
| -16% | -$9.91M |
|
|
CERN
453
DELISTED
Cerner Corp
CERN
| $57.6M | 0.03% |
840,526
+599,721
| +249% | +$41.2M |
|
454
BridgeBio Pharma
BBIO
$16.8B
| $57.6M | 0.03% |
1,765,864
-20,175
| -1% | -$615K |
|
455
CMS Energy
CMS
$23B
| $57.5M | 0.03% |
983,633
+68,080
| +7% | +$3.94M |
|
|
WIRE
456
DELISTED
Encore Wire Corp
WIRE
| $57.3M | 0.03% |
1,174,709
+94,109
| +9% | +$4.32M |
|
457
Hewlett Packard
HPE
$60.4B
| $56.7M | 0.03% |
5,829,055
-1,954,784
| -25% | -$19.2M |
|
458
Jones Lang LaSalle
JLL
$15.9B
| $56.5M | 0.03% |
546,516
-35,147
| -6% | -$3.62M |
|
459
Belden
BDC
$4.09B
| $56.2M | 0.03% |
1,727,004
-3,271,687
| -65% | -$109M |
|
460
J.M. Smucker
SJM
$13.2B
| $55.2M | 0.03% |
521,655
+152,133
| +41% | +$17.1M |
|
461
Moderna
MRNA
$22.1B
| $55.1M | 0.03% |
857,757
+776,564
| +956% | +$42.5M |
|
|
CSW
462
CSW Industrials
CSW
$4.87B
| $54.9M | 0.03% |
794,410
-95,922
| -11% | -$6.47M |
|
463
Royal Bank of Canada
RY
$295B
| $54.5M | 0.03% |
805,615
-154,596
| -16% | -$9.83M |
|
|
GRA
464
DELISTED
W.R. Grace & Co.
GRA
| $54.2M | 0.03% |
1,067,118
-1,037,656
| -49% | -$49.2M |
|
465
Allstate
ALL
$70.1B
| $53.8M | 0.03% |
554,862
-75,889
| -12% | -$7.46M |
|
466
Healthpeak Properties
DOC
$15.7B
| $53.7M | 0.03% |
1,949,117
-357,914
| -16% | -$9.14M |
|
467
ExxonMobil
XOM
$634B
| $53.5M | 0.03% |
1,196,643
-845,919
| -41% | -$37.9M |
|
468
C.H. Robinson
CHRW
$20B
| $53.5M | 0.03% |
676,139
+418,493
| +162% | +$31.6M |
|
469
Rexford Industrial Realty
REXR
$8.64B
| $53.3M | 0.03% |
1,286,576
+457,078
| +55% | +$18.4M |
|
470
Chegg
CHGG
$121M
| $53.2M | 0.03% |
790,196
-121,901
| -13% | -$6.51M |
|
|
PPL
471
PPL Corp
PPL
$27.3B
| $53M | 0.03% |
2,052,656
-2,036,596
| -50% | -$53M |
|
472
Alcon
ALC
$33.7B
| $53M | 0.03% |
925,043
-159,130
| -15% | -$9.01M |
|
473
Everest Group
EG
$15.8B
| $53M | 0.03% |
257,110
-19,672
| -7% | -$3.83M |
|
474
Reynolds Consumer Products
REYN
$5.44B
| $53M | 0.03% |
1,525,065
-362,151
| -19% | -$11.8M |
|
475
Duke Energy
DUK
$101B
| $52.9M | 0.03% |
662,715
-193,173
| -23% | -$16.3M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.